Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Robert Hagemann, a director at Graphic Packaging Holding Co (NYSE: GPK), has executed a significant direct purchase of common stock. The transaction, which took place on May 8, 2026, involved the acquisition of 14,000 shares for a total consideration of $153,991. This move comes amid a period of recent financial outperformance for the company, even…
Christopher Ryan Sullivan, the Chief Financial Officer of Avalo Therapeutics, Inc. (NASDAQ: AVTX), has completed a series of transactions involving the company's common stock. According to a Form 4 filing submitted to the Securities and Exchange Commission on May 11, 2026, these movements were conducted under a Rule 10b5-1 trading plan that Sulliva…
Director Shawn McCormick has completed a sale of common stock in Inspire Medical Systems, Inc. (NASDAQ:INSP). The transaction occurred on May 8, 2026, involving the sale of 696 shares at a price of $45.31 per share, resulting in total proceeds of $31,535. This divestment was executed via a Rule 10b5-1 trading plan that McCormick had established on …
Freshpet, Inc. (NASDAQ:FRPT) has seen notable insider activity following a period of stock price fluctuation. On May 8, 2026, director George N. Walter executed a direct purchase of common stock, signaling a significant personal investment in the company's equity at a time when the share price is trading near its annual lows. This transaction occur…
Catalyst Pharmaceuticals announced its financial results for Q1 2026, highlighting a 5.6% year-over-year increase in total product revenue to $149.3 million, driven by strong sales growth of their key promoted products FIRDAPSE® and AGAMREE®. Net income rose to $63.7 million GAAP and $100.3 million non-GAAP, reflecting improved operating performanc…
Columbia Financial, Inc. announced the commencement of its second-step conversion offering of up to 192.6 million common shares to convert from a mutual holding company to a stock holding company. The company has received all necessary regulatory approvals and conditional approval to acquire Northfield Bancorp, Inc., which will close immediately fo…
SI-BONE, Inc. announced its financial results for the first quarter of 2026, revealing an 11.2% worldwide revenue growth to $52.6 million and an improved net loss of $4.3 million. The company also raised its 2026 revenue guidance to between $230 million and $233 million, reflecting confidence in continuing growth driven by expanded product adoption…
Victoria’s Secret & Co. filed a supplement to its proxy statement and issued a letter to shareholders addressing a proxy contest launched by BBRC International and its Chairman Brett Blundy, opposing the re-election of two Board members. The Company highlights its strong operational and financial performance under CEO Hillary Super, including a 152…
SPS Commerce Inc. (NASDAQ: SPSC) director Marty M. Reaume conducted a series of equity transactions on May 7, 2026, involving both the exercise of stock options and the subsequent sale of common stock. These activities were executed under a pre-arranged Rule 10b5-1 trading plan that had been established on September 10, 2025. The movements occurred…
W. Robert Mudge, a member of the Board of Trustees for Eversource Energy (NYSE: ES), has expanded his position in the utility provider through an indirect purchase of common shares. The transaction occurred on May 8, 2026, involving the acquisition of 750 shares at a price point of $66.485 per share. This specific buy represents a total investment …
Jeffrey Zerillo, the Senior Vice President of Operations at Prestige Consumer Healthcare Inc. (NASDAQ:PBH), has completed two separate transactions involving the sale of company common stock. These disposals occurred on May 7, 2026, according to recent filings with the SEC. The sales took place against a backdrop of recent stock price volatility an…
A recent regulatory filing has revealed that Monica Mijaleski, a director at Taboola.com Ltd. (NASDAQ: TBLA), completed a sale of her ordinary shares on May 8, 2026. The transaction involved the disposal of 61,000 shares at a price point of $5.04 per share, resulting in total proceeds of $307,440. According to the filing, this specific divestment w…
Christoph Glingener, the Chief Technology Officer of ADTRAN Holdings, Inc. (NASDAQ:ADTN), has completed a series of stock transactions totaling approximately $2,219,844. These sales, which occurred over two days in May 2026, were executed following the exercise of various stock options. The activity was conducted under a Rule 10b5-1 trading plan th…
Getty Images announced its first quarter 2026 financial results with a modest 1.1% revenue increase and a significant reduction in net loss compared to last year. Despite challenges in segments like Agency and microstock, the corporate subscription business grew, and the company maintained its full-year revenue and adjusted EBITDA guidance. The ong…
Perspective Therapeutics reported Q1 2026 financial results showing increased cash reserves to $271 million following a successful equity offering and detailed progress across its three clinical-stage oncology programs targeting neuroendocrine tumors, melanoma, and FAP-positive solid tumors with multiple clinical catalysts expected throughout 2026.…
Oculis Holding AG reported strong Q1 2026 results highlighting significant progress across its late-stage ophthalmology pipeline. The company completed last patient visit in its pivotal Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema with topline data expected in June 2026, planning NDA submission by year-end. Its genotype-driven Licami…
Health Catalyst, a healthcare intelligence company, reported Q1 2026 financial results showing total revenue of $70.8 million, down 11% year-over-year, with adjusted EBITDA of $9.1 million, up 46%. The company undertook a strategic reset focusing on its technology opportunities, resulting in a significant goodwill impairment charge of $95.5 million…
MARA Holdings, Inc. announced its preliminary, unaudited financial results for the first quarter of 2026 and invited investors to a webcast and conference call to discuss the results. The company continues to focus on deploying digital energy technologies to optimize energy systems and reduce energy demands in computing applications.
Roivant Sciences Ltd. announced it will report financial results for Q4 and fiscal year ended March 31, 2026, and provide an update on its biopharmaceutical pipeline on May 20, 2026. The company develops various drug candidates and utilizes nimble subsidiaries to advance their pipeline, aiming to improve patient outcomes.
Immunovant, a clinical-stage immunology company focused on autoimmune diseases, announced it will report its financial results for the fourth quarter and fiscal year ended March 31, 2026, via a webcast and conference call on May 20, 2026. The company will also provide a business update during the call.
Rigetti Computing announced its financial results for Q1 2026, highlighting revenue growth driven by new quantum system sales and technology milestones. The company launched its 108-qubit Cepheus-1-108Q system, expanded international presence, and confirmed strong cash reserves and no debt position to support ongoing R&D and commercial opportunitie…
Medallion Bank has entered into a multi-year strategic partnership with fintech firm Together Loans to expand consumer loan offerings based on cosigner trust rather than credit scores. This marks the Bank's fifth fintech alliance, contributing to a substantial increase in loan originations through strategic partnerships from $203.6 million in 2024 …
Elicio Therapeutics announced its first quarter 2026 financial results, highlighting a net loss of $11.8 million and cash runway expected to extend into Q4 2026 following recent fundraising efforts. The company provided updates on its Phase 2 AMPLIFY-7P study evaluating ELI-002 7P, an immunotherapy targeting KRAS-driven pancreatic ductal adenocarci…
Nasdaq published its end-of-month short interest data as of April 30, 2026, showing a slight increase in short interest shares and days of average volume across its Global Market and Capital Market securities compared to the prior reporting period. Total short interest across all Nasdaq securities rose moderately, indicating stable but marginally h…
CVRx, Inc. reported a 20% increase in total revenue for Q1 2026 to $14.8 million, driven by a 22% growth in U.S. revenue attributed to expanded sales territories and increased awareness of its Barostim device. The company initiated the BENEFIT-HF clinical trial with the first site activated and patient enrolled in Q2 2026. CVRx maintained its 2026 …
